Response to Walsh

J Natl Cancer Inst. 2019 Jul 1;111(7):748. doi: 10.1093/jnci/djy187.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 5-alpha Reductase Inhibitors*
  • Humans
  • Male
  • Oxidoreductases
  • Prospective Studies
  • Prostatic Neoplasms*

Substances

  • 5-alpha Reductase Inhibitors
  • Oxidoreductases